This inventor holds 1 USPTO granted patent. Top assignee: Karyopharm Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Clifton Hamilton: Innovator in Pharmaceutical Co-Crystals
Introduction
Clifton Hamilton is a notable inventor based in Devens, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-crystal forms of selinexor. His work is essential for advancing treatment options in various diseases.
Latest Patents
Hamilton holds 1 patent related to his innovative work. His patent focuses on co-crystal forms of selinexor, specifically two co-crystal forms with succinic acid as the coformer and another co-crystal form with vanillin as the coformer. The patent also encompasses processes for preparing these co-crystal forms and pharmaceutical compositions that utilize them for treating diseases.
Career Highlights
Clifton Hamilton is associated with Karyopharm Therapeutics Inc., where he applies his expertise in pharmaceutical development. His role at the company allows him to contribute to groundbreaking research and innovation in the field.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Clifton Hamilton's work in developing co-crystal forms of selinexor represents a significant advancement in pharmaceutical science. His contributions are vital for improving treatment methodologies and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile